Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.05 CAD | -0.06% | -1.09% | -1.84% |
17/05 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
17/05 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.84% | 7.82Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- BioSyent Says FeraMAX Named #1 Recommended Iron Supplement in Canada